Varin-Blank N - Search Results

1

Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.

Brugnoli F, Lambertini E, Varin-Blank N, Piva R, Marchisio M, Grassilli S, Miscia S, Capitani S, Bertagnolo V. Brugnoli F, et al. Exp Cell Res. 2010 Jan 1;316(1):38-47. doi: 10.1016/j.yexcr.2009.09.004. Epub 2009 Sep 10. Exp Cell Res. 2010. PMID: 19747912

2

Vav1 is a component of transcriptionally active complexes.

Houlard M, Arudchandran R, Regnier-Ricard F, Germani A, Gisselbrecht S, Blank U, Rivera J, Varin-Blank N. Houlard M, et al. J Exp Med. 2002 May 6;195(9):1115-27. doi: 10.1084/jem.20011701. J Exp Med. 2002. PMID: 11994417 Free PMC article.

3

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Souissi I, Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, Roger C, Dusanter-Fourt I, Varin-Blank N, Cao A, Metelev V, Baran-Marszak F, Fagard R. Souissi I, et al. BMC Cell Biol. 2011 Apr 12;12:14. doi: 10.1186/1471-2121-12-14. BMC Cell Biol. 2011. PMID: 21486470 Free PMC article.

4

Induction of endoplasmic reticulum calcium pump expression during early leukemic B cell differentiation.

Aït Ghezali L, Arbabian A, Roudot H, Brouland JP, Baran-Marszak F, Salvaris E, Boyd A, Drexler HG, Enyedi A, Letestu R, Varin-Blank N, Papp B. Aït Ghezali L, et al. Among authors: varin blank n. J Exp Clin Cancer Res. 2017 Jun 26;36(1):87. doi: 10.1186/s13046-017-0556-7. J Exp Clin Cancer Res. 2017. PMID: 28651627 Free PMC article.

5

A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.

Souissi I, Ladam P, Cognet JA, Le Coquil S, Varin-Blank N, Baran-Marszak F, Metelev V, Fagard R. Souissi I, et al. Mol Cancer. 2012 Mar 16;11:12. doi: 10.1186/1476-4598-11-12. Mol Cancer. 2012. PMID: 22423663 Free PMC article.

6

Characterization of VIK-1: a new Vav-interacting Kruppel-like protein.

Houlard M, Romero-Portillo F, Germani A, Depaux A, Regnier-Ricard F, Gisselbrecht S, Varin-Blank N. Houlard M, et al. Oncogene. 2005 Jan 6;24(1):28-38. doi: 10.1038/sj.onc.1208043. Oncogene. 2005. PMID: 15558030

7

Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner.

Romero F, Germani A, Puvion E, Camonis J, Varin-Blank N, Gisselbrecht S, Fischer S. Romero F, et al. J Biol Chem. 1998 Mar 6;273(10):5923-31. doi: 10.1074/jbc.273.10.5923. J Biol Chem. 1998. PMID: 9488731 Free article.

8

hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.

Germani A, Romero F, Houlard M, Camonis J, Gisselbrecht S, Fischer S, Varin-Blank N. Germani A, et al. Mol Cell Biol. 1999 May;19(5):3798-807. doi: 10.1128/MCB.19.5.3798. Mol Cell Biol. 1999. PMID: 10207103 Free PMC article.

9

Dimerization of hSiah proteins regulates their stability.

Depaux A, Regnier-Ricard F, Germani A, Varin-Blank N. Depaux A, et al. Biochem Biophys Res Commun. 2006 Sep 29;348(3):857-63. doi: 10.1016/j.bbrc.2006.07.092. Epub 2006 Jul 28. Biochem Biophys Res Commun. 2006. PMID: 16899216

10

SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis.

Germani A, Bruzzoni-Giovanelli H, Fellous A, Gisselbrecht S, Varin-Blank N, Calvo F. Germani A, et al. Oncogene. 2000 Dec 7;19(52):5997-6006. doi: 10.1038/sj.onc.1204002. Oncogene. 2000. PMID: 11146551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters